SCHEMBL16701743

SCHEMBL16701743

O=C(O)N(CCCl)c1ccc([N+](=O)[O-])c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.44
ATM Q13315 1/20 0.44
CASP6 P55212 1/20 0.36
ALDH1A1 P00352 4/20 0.35
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP1A2 P05177 1/20 0.35
CTSK P43235 1/20 0.34
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
SNCA P37840 1/20 0.34
CYP19A1 P11511 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HCAR3 P49019 1/20 0.33
GSTO1 P78417 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18154007 0.80 ATM (0.43) TDP1ATMCASP6ALDH1A1TSHR
SCHEMBL8799973 0.79 CYP1A2 (0.39) TDP1ALDH1A1TSHRSMN1; SMN2CYP1A2
SCHEMBL8799963 0.79 CYP1A2 (0.39) TDP1ALDH1A1TSHRSMN1; SMN2CYP1A2
SCHEMBL8618765 0.78 SMN1; SMN2 (0.50) TDP1ALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL8952221 0.78 SMN1; SMN2 (0.50) TDP1ALDH1A1TSHRSMN1; SMN2MAPT
SCHEMBL18147353 0.76 ATM (0.50) TDP1ATMCASP6ALDH1A1TSHR
SCHEMBL18147351 0.76 ATM (0.50) TDP1ATMCASP6ALDH1A1TSHR
SCHEMBL7900446 0.74 ALDH1A1 (0.59) TDP1ATMALDH1A1TSHRSMN1; SMN2
SCHEMBL8618010 0.71 ALDH1A1 (0.44) ALDH1A1TSHRSMN1; SMN2CYP1A2MAPT
SCHEMBL14180498 0.70 TDP1 (0.55) TDP1ATMALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3066098-A1 SUBSTITUTED URACILS AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2016-09-14 EP disclosed
WO-2015067630-A1 SUBSTITUTED URACILS AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-05-14 WO disclosed